Sagimet Biosciences Inc.SGMTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR+505.2%
5Y CAGR-12.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+505.2%/yr
Annual compound
5Y CAGR
-12.6%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$35.02M-53.8%
2024$75.84M+0.9%
2023$75.14M+47456.3%
2022$158000.00-99.7%
2021$56.73M-17.4%
2020$68.70M+572.8%
2019$10.21M-